[Korea Biomedical Review] Korea’s 1st long-term continuous ECG device gets FDA approval | Admin 2022-10-19 11:51:56 |
---|---|
[Korea Biomedical Review] Korea’s 1st long-term continuous ECG device gets FDA approval OCT.18.2022
- AT-Patch (ATP-C130) is the first domestic long-term continuous wearable ECG device to be licensed in the U.S. (FDA Clearance, Medical Device Class Ⅱ) - Although it is a single channel, it is possible to record clear ECG signals including P-Wave. - The CEO said "We will accelerate its entry into the U.S. Market as it has successfully passed the largest regulatory gateway.
http://www.koreabiomed.com/news/articleView.html?idxno=14822
|
|
File :
|